These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30025978)

  • 1. Changes in Patient-reported Swallow Function in the Long Term After Chemoradiotherapy for Oropharyngeal Carcinoma.
    Martin A; Murray L; Sethugavalar B; Buchan C; Williams GF; Sen M; Prestwich RJD
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):756-763. PubMed ID: 30025978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of prophylactic gastrostomy or reactive NG tube upon patient-reported long term swallow function following chemoradiotherapy for oropharyngeal carcinoma: A matched pair analysis.
    Sethugavalar B; Teo MT; Buchan C; Ermiş E; Williams GF; Sen M; Prestwich RJD
    Oral Oncol; 2016 Aug; 59():80-85. PubMed ID: 27424186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term patient reported swallowing function following chemoradiotherapy for oropharyngeal carcinoma.
    Dixon L; Ramasamy S; Cardale K; Dyker K; Garcez K; Lee LW; McPartlin A; Murray P; Sen M; Slevin N; Sykes A; Prestwich R; Thomson D
    Radiother Oncol; 2018 Sep; 128(3):452-458. PubMed ID: 29937211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of choice of feeding tubes on long-term swallow function following chemoradiotherapy for oropharyngeal carcinoma.
    Prestwich RJD; Murray LJ; Williams GF; Tease E; Taylor L; George C; Cardale K; Dyker KE; Murray P; Sen M; Ramasamy S
    Acta Oncol; 2019 Aug; 58(8):1187-1196. PubMed ID: 31032694
    [No Abstract]   [Full Text] [Related]  

  • 5. Predictors of Patient-Reported Dysphagia Following IMRT Plus Chemotherapy in Oropharyngeal Cancer.
    Orlandi E; Miceli R; Infante G; Mirabile A; Alterio D; Cossu Rocca M; Denaro N; Vigna-Taglianti R; Merlotti A; Schindler A; Pizzorni N; Fallai C; Licitra L; Bossi P
    Dysphagia; 2019 Feb; 34(1):52-62. PubMed ID: 29948260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term swallow function after chemoradiotherapy for oropharyngeal cancer: the influence of a prophylactic gastrostomy or reactive nasogastric tube.
    Prestwich RJ; Teo MT; Gilbert A; Williams G; Dyker KE; Sen M
    Clin Oncol (R Coll Radiol); 2014 Feb; 26(2):103-9. PubMed ID: 24246275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma.
    Goepfert RP; Lewin JS; Barrow MP; Fuller CD; Lai SY; Song J; Hobbs BP; Gunn GB; Beadle BM; Rosenthal DI; Garden AS; Kies MS; Papadimitrakopoulou VA; Schwartz DL; Hutcheson KA
    Laryngoscope; 2017 Apr; 127(4):842-848. PubMed ID: 27440393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing.
    ; Grant S; Kamal M; Mohamed ASR; Zaveri J; Barrow MP; Gunn GB; Lai SY; Lewin JS; Rosenthal DI; Wang XS; Fuller CD; Hutcheson KA
    Cancer; 2019 May; 125(10):1654-1664. PubMed ID: 30633325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Objective Ratings of Swallowing and Dysphagia-Specific Quality of Life in Patients Receiving (Chemo)radiotherapy for Oropharyngeal Cancer.
    Wishart LR; Harris GB; Cassim N; Alimin S; Liao T; Brown B; Ward EC; Nund RL
    Dysphagia; 2022 Aug; 37(4):1014-1021. PubMed ID: 34625841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy.
    Goepfert RP; Lewin JS; Barrow MP; Gunn GB; Fuller CD; Beadle BM; Garden AS; Rosenthal DI; Kies MS; Papadimitrakopoulou V; Lai SY; Gross ND; Schwartz DL; Hutcheson KA
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):700-708. PubMed ID: 27485284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Swallowing outcomes for patients with oropharyngeal squamous cell carcinoma treated with primary (chemo)radiation therapy receiving either prophylactic gastrostomy or reactive nasogastric tube: A prospective cohort study.
    Goff D; Coward S; Fitzgerald A; Paleri V; Moor JW; Patterson JM
    Clin Otolaryngol; 2017 Dec; 42(6):1135-1140. PubMed ID: 28128886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of patient reported swallow function with the Functional Assessment of Cancer Therapy (FACT), MD Anderson Dysphagia Inventory (MDADI) and the Sydney Swallow Questionnaire (SSQ) in head and neck cancer patients.
    Peng LC; Hui X; Cheng Z; Bowers MR; Moore J; Cecil E; Choflet A; Thompson A; Muse M; Kiess AP; Page BR; Gourin CG; Fakhry C; Szczesniak M; Maclean J; Wu P; Cook I; McNutt TR; Quon H
    Oral Oncol; 2018 Sep; 84():25-30. PubMed ID: 30115472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional swallowing outcomes following transoral robotic surgery vs primary chemoradiotherapy in patients with advanced-stage oropharynx and supraglottis cancers.
    More YI; Tsue TT; Girod DA; Harbison J; Sykes KJ; Williams C; Shnayder Y
    JAMA Otolaryngol Head Neck Surg; 2013 Jan; 139(1):43-8. PubMed ID: 23247974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-reported versus physiologic swallowing outcomes in patients with head and neck cancer after chemoradiation.
    Kirsh E; Naunheim M; Holman A; Kammer R; Varvares M; Goldsmith T
    Laryngoscope; 2019 Sep; 129(9):2059-2064. PubMed ID: 30582151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrostomy Utilization by Oropharyngeal Cancer Patients Is Partially Driven by Swallowing Function.
    Chhabria K; Kansara S; Badr H; Stach C; Vernese M; Lerner A; Harms A; Hernandez DJ; Huang AT; Chen G; Parke RB; Charnitsky S; Sandulache VC
    Laryngoscope; 2020 Sep; 130(9):2153-2159. PubMed ID: 31566749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year swallowing outcomes following transoral laser microsurgery +/- adjuvant therapy versus primary chemoradiotherapy for advanced stage oropharyngeal squamous cell carcinoma.
    O'Hara J; Goff D; Cocks H; Moor J; Hartley C; Muirhead C; Patterson J
    Clin Otolaryngol; 2016 Apr; 41(2):169-75. PubMed ID: 26135849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is a clinically relevant difference in MDADI scores between groups of head and neck cancer patients?
    Hutcheson KA; Barrow MP; Lisec A; Barringer DA; Gries K; Lewin JS
    Laryngoscope; 2016 May; 126(5):1108-13. PubMed ID: 26542529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
    Ursino S; Calistri E; De Felice F; Bonomo P; Desideri I; Franco P; Arcadipane F; Colosimo C; Mazzola R; Maddalo M; Gonnelli A; Malfatti G; Morganti R; Musio D; Paiar F
    Dysphagia; 2023 Feb; 38(1):159-170. PubMed ID: 35587295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transoral laser microsurgery ± adjuvant therapy versus chemoradiotherapy for stage III and IVA oropharyngeal squamous cell carcinoma: Preliminary comparison of early swallowing outcomes.
    O'Hara J; Cosway B; Muirhead C; Leonard N; Goff D; Patterson J
    Head Neck; 2015 Oct; 37(10):1488-94. PubMed ID: 24891273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term quality of life after swallowing and salivary-sparing chemo-intensity modulated radiation therapy in survivors of human papillomavirus-related oropharyngeal cancer.
    Vainshtein JM; Moon DH; Feng FY; Chepeha DB; Eisbruch A; Stenmark MH
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):925-33. PubMed ID: 25832685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.